39 related articles for article (PubMed ID: 25876789)
1. Clinicoradiopathological correlation of symptomatic focal bone marrow lesions in Waldenström Macroglobulinaemia.
Arulogun SO; Abbasi MA; Pomplun S; O'Neill AT; Wan S; Wechalekar A; D'Sa SP
Leuk Lymphoma; 2022 Jun; 63(6):1496-1499. PubMed ID: 35067139
[No Abstract] [Full Text] [Related]
2. Reply to “Response to “CD20 positive cells are undetectable in the majority of multiple myeloma cell lines and are not associated with a cancer stem cell phenotype”. Haematologica 2012;97(7):1110-1114.
Paíno T; Paiva B; San Miguel J
Haematologica; 2013 Jan; 98(1):e10. PubMed ID: 23397607
[No Abstract] [Full Text] [Related]
3. Refractory anemia with ring sideroblasts and RARS with thrombocytosis.
Patnaik MM; Tefferi A
Am J Hematol; 2015 Jun; 90(6):549-59. PubMed ID: 25899435
[TBL] [Abstract][Full Text] [Related]
4. Aberrant expression of the microRNA cluster in 14q32 is associated with del(5q) myelodysplastic syndrome and lenalidomide treatment.
Krejčík Z; Beličková M; Hruštincová A; Kléma J; Zemanová Z; Michalová K; Čermák J; Jonášová A; Dostálová Merkerová M
Cancer Genet; 2015 Apr; 208(4):156-61. PubMed ID: 25883014
[TBL] [Abstract][Full Text] [Related]
5. CD38-Targeted Immunochemotherapy in Refractory Multiple Myeloma: A New Horizon.
Laubach JP; Richardson PG
Clin Cancer Res; 2015 Jun; 21(12):2660-2. PubMed ID: 25878332
[TBL] [Abstract][Full Text] [Related]
6. Pushing the envelope-nonmyeloablative and reduced intensity preparative regimens for allogeneic hematopoietic transplantation.
Pingali SR; Champlin RE
Bone Marrow Transplant; 2015 Sep; 50(9):1157-67. PubMed ID: 25985053
[TBL] [Abstract][Full Text] [Related]
7. Lenalidomide Enhances Immune Checkpoint Blockade-Induced Immune Response in Multiple Myeloma.
Görgün G; Samur MK; Cowens KB; Paula S; Bianchi G; Anderson JE; White RE; Singh A; Ohguchi H; Suzuki R; Kikuchi S; Harada T; Hideshima T; Tai YT; Laubach JP; Raje N; Magrangeas F; Minvielle S; Avet-Loiseau H; Munshi NC; Dorfman DM; Richardson PG; Anderson KC
Clin Cancer Res; 2015 Oct; 21(20):4607-18. PubMed ID: 25979485
[TBL] [Abstract][Full Text] [Related]
8. Multiple myeloma acquires resistance to EGFR inhibitor via induction of pentose phosphate pathway.
Chen Y; Huang R; Ding J; Ji D; Song B; Yuan L; Chang H; Chen G
Sci Rep; 2015 Apr; 5():9925. PubMed ID: 25894462
[TBL] [Abstract][Full Text] [Related]
9. A cost-effectiveness analysis of real-world treatment for elderly patients with multiple myeloma using a full disease model.
Blommestein HM; Verelst SG; de Groot S; Huijgens PC; Sonneveld P; Uyl-de Groot CA
Eur J Haematol; 2016 Feb; 96(2):198-208. PubMed ID: 25892333
[TBL] [Abstract][Full Text] [Related]
10. Real-world chemotherapy treatment patterns in metastatic non-small cell lung cancer: Are patients undertreated?
Sacher AG; Le LW; Lau A; Earle CC; Leighl NB
Cancer; 2015 Aug; 121(15):2562-9. PubMed ID: 25891153
[TBL] [Abstract][Full Text] [Related]
11. Predicting poor peripheral blood stem cell collection in patients with multiple myeloma receiving pre-transplant induction therapy with novel agents and mobilized with cyclophosphamide plus granulocyte-colony stimulating factor: results from a Gruppo Italiano Malattie EMatologiche dell'Adulto Multiple Myeloma Working Party study.
Musto P; Simeon V; Grossi A; Gay F; Bringhen S; Larocca A; Guariglia R; Pietrantuono G; Villani O; D'Arena G; Cuomo C; Musto C; Morabito F; Petrucci MT; Offidani M; Zamagni E; Tacchetti P; Conticello C; Milone G; Palumbo A; Cavo M; Boccadoro M
Stem Cell Res Ther; 2015 Apr; 6(1):64. PubMed ID: 25889496
[TBL] [Abstract][Full Text] [Related]
12. The non-peptide thrombopoietin receptor agonist eltrombopag stimulates megakaryopoiesis in bone marrow cells from patients with relapsed multiple myeloma.
Jeong JY; Levine MS; Abayasekara N; Berliner N; Laubach J; Vanasse GJ
J Hematol Oncol; 2015 Apr; 8():37. PubMed ID: 25886818
[TBL] [Abstract][Full Text] [Related]
13. The HSP90 inhibitor ganetespib: A potential effective agent for Acute Myeloid Leukemia in combination with cytarabine.
Lazenby M; Hills R; Burnett AK; Zabkiewicz J
Leuk Res; 2015 Jun; 39(6):617-24. PubMed ID: 25882550
[TBL] [Abstract][Full Text] [Related]
14. A retrospective analysis of RET translocation, gene copy number gain and expression in NSCLC patients treated with vandetanib in four randomized Phase III studies.
Platt A; Morten J; Ji Q; Elvin P; Womack C; Su X; Donald E; Gray N; Read J; Bigley G; Blockley L; Cresswell C; Dale A; Davies A; Zhang T; Fan S; Fu H; Gladwin A; Harrod G; Stevens J; Williams V; Ye Q; Zheng L; de Boer R; Herbst RS; Lee JS; Vasselli J
BMC Cancer; 2015 Mar; 15():171. PubMed ID: 25881079
[TBL] [Abstract][Full Text] [Related]
15. Aurora A Kinase Inhibition Selectively Synergizes with Histone Deacetylase Inhibitor through Cytokinesis Failure in T-cell Lymphoma.
Zullo KM; Guo Y; Cooke L; Jirau-Serrano X; Mangone M; Scotto L; Amengual JE; Mao Y; Nandakumar R; Cremers S; Duong J; Mahadevan D; O'Connor OA
Clin Cancer Res; 2015 Sep; 21(18):4097-109. PubMed ID: 25878331
[TBL] [Abstract][Full Text] [Related]
16. Obinutuzumab (GA101) for the treatment of chronic lymphocytic leukemia and other B-cell non-hodgkin's lymphomas: a glycoengineered type II CD20 antibody.
Goede V; Klein C; Stilgenbauer S
Oncol Res Treat; 2015; 38(4):185-92. PubMed ID: 25877943
[TBL] [Abstract][Full Text] [Related]
17. Lymphoplasmacytic lymphoma with IgG-κ paraproteinemia presenting as a hepatic bulky mass.
Higuchi M; Senoo T; Morita C; Furugo I; Hamada T; Ohshima K
J Clin Exp Hematop; 2022; 62(4):273-278. PubMed ID: 36575005
[TBL] [Abstract][Full Text] [Related]
18. [CD20-positive plasma cell myeloma with lymphoplasmacytoid appearance mimicking low-grade B-cell lymphoma].
Haji S; Abe Y; Tsuda M; Toyoda K; Choi I; Suehiro Y; Shiratsuchi M; Kiyasu J; Uike N
Rinsho Ketsueki; 2015 Mar; 56(3):335-8. PubMed ID: 25876789
[TBL] [Abstract][Full Text] [Related]
19. CD20-negative low-grade B cell lymphoma showing immunophenotypic and genotypic features resembling plasma cell myeloma.
Tabata R; Yasumizu R; Tabata C; Kojima M
Pathol Res Pract; 2013 Jul; 209(7):459-62. PubMed ID: 23707547
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
